Selected research
Industry Growth & Trends
Global Biliary Tumor Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Biliary Tumor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Biliary Tumor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Biliary Tumor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biliary Tumor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Biliary Tumor market include Novartis, GlaxoSmithKline, Southwest Oncology Group, NuCana and NeoGenomics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Biliary Tumor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Biliary Tumor market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biliary Tumor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biliary Tumor.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Biliary Tumor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Biliary Tumor Market by Company
Novartis
GlaxoSmithKline
Southwest Oncology Group
NuCana
NeoGenomics
Biliary Tumor Segment by Type
Mecine
Surgery
Other
Biliary Tumor Segment by Application
Hospitals
Clinics
Other
Biliary Tumor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biliary Tumor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biliary Tumor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biliary Tumor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Biliary Tumor companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Mecine
- Surgery
- Other
Applications
- Hospitals
- Clinics
- Other
Companies covered
- Novartis
- GlaxoSmithKline
- Southwest Oncology Group
- NuCana
- NeoGenomics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Biliary Tumor Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Biliary Tumor Market Size by Region (2021-2032)
- 1.4.1 Global Biliary Tumor Market Size by Region (2021-2026)
- 1.4.2 Global Biliary Tumor Market Size by Region (2027-2032)
- 1.5 Key Regions Biliary Tumor Market Size (2021-2032)
- 1.5.1 North America Biliary Tumor Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Biliary Tumor Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Biliary Tumor Market Size Growth Rate (2021-2032)
- 1.5.4 South America Biliary Tumor Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Biliary Tumor Market Size Growth Rate (2021-2032)
2 Biliary Tumor Market by Type
- 2.1 Type Introduction
- 2.1.1 Mecine
- 2.1.2 Surgery
- 2.1.3 Other
- 2.2 Global Biliary Tumor Market Size by Type
- 2.2.1 Global Biliary Tumor Market Size Overview by Type (2021-2032)
- 2.2.2 Global Biliary Tumor Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Biliary Tumor Market Size Forecasted by Type (2027-2032)
- 2.3 Global Biliary Tumor Market Size by Regions
- 2.3.1 North America Biliary Tumor Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Biliary Tumor Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Biliary Tumor Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Biliary Tumor Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Biliary Tumor Market Size Breakdown by Type (2021-2026)
3 Biliary Tumor Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals
- 3.1.2 Clinics
- 3.1.3 Other
- 3.2 Global Biliary Tumor Market Size by Application
- 3.2.1 Global Biliary Tumor Market Size Overview by Application (2021-2032)
- 3.2.2 Global Biliary Tumor Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Biliary Tumor Market Size Forecasted by Application (2027-2032)
- 3.3 Global Biliary Tumor Market Size by Regions
- 3.3.1 North America Biliary Tumor Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Biliary Tumor Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Biliary Tumor Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Biliary Tumor Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Biliary Tumor Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Biliary Tumor Industry Trends
- 4.2 Biliary Tumor Industry Drivers
- 4.3 Biliary Tumor Industry Opportunities and Challenges
- 4.4 Biliary Tumor Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Biliary Tumor Revenue (2021-2026)
- 5.2 Global Biliary Tumor Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Biliary Tumor Key Company Headquarters & Area Served
- 5.4 Global Biliary Tumor Company, Product Type & Application
- 5.5 Global Biliary Tumor Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Biliary Tumor Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Biliary Tumor Players Market Share by Revenue in 2025
- 5.6.3 2025 Biliary Tumor Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Novartis
- 6.1.1 Novartis Company Information
- 6.1.2 Novartis Business Overview
- 6.1.3 Novartis Biliary Tumor Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Novartis Biliary Tumor Product Portfolio
- 6.1.5 Novartis Recent Developments
- 6.2 GlaxoSmithKline
- 6.2.1 GlaxoSmithKline Company Information
- 6.2.2 GlaxoSmithKline Business Overview
- 6.2.3 GlaxoSmithKline Biliary Tumor Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 GlaxoSmithKline Biliary Tumor Product Portfolio
- 6.2.5 GlaxoSmithKline Recent Developments
- 6.3 Southwest Oncology Group
- 6.3.1 Southwest Oncology Group Company Information
- 6.3.2 Southwest Oncology Group Business Overview
- 6.3.3 Southwest Oncology Group Biliary Tumor Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Southwest Oncology Group Biliary Tumor Product Portfolio
- 6.3.5 Southwest Oncology Group Recent Developments
- 6.4 NuCana
- 6.4.1 NuCana Company Information
- 6.4.2 NuCana Business Overview
- 6.4.3 NuCana Biliary Tumor Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 NuCana Biliary Tumor Product Portfolio
- 6.4.5 NuCana Recent Developments
- 6.5 NeoGenomics
- 6.5.1 NeoGenomics Company Information
- 6.5.2 NeoGenomics Business Overview
- 6.5.3 NeoGenomics Biliary Tumor Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 NeoGenomics Biliary Tumor Product Portfolio
- 6.5.5 NeoGenomics Recent Developments
7 North America
- 7.1 North America Biliary Tumor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Biliary Tumor Market Size by Country (2021-2026)
- 7.3 North America Biliary Tumor Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Biliary Tumor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Biliary Tumor Market Size by Country (2021-2026)
- 8.3 Europe Biliary Tumor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Biliary Tumor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Biliary Tumor Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Biliary Tumor Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Biliary Tumor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Biliary Tumor Market Size by Country (2021-2026)
- 10.3 South America Biliary Tumor Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Biliary Tumor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Biliary Tumor Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Biliary Tumor Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst